ArticleClinical and public health guidelines2024
Is 'too much medicine' a guideline-driven phenomenon? Ten years' report and reflections of the Guidelines International Network Multimorbidity Working Group.
Article in Clinical and public health guidelines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Changing of the Guard. A dialogue between the former and the new Editor-in-Chief.The European journal of general practice · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Guidelines International Network Multimorbidity Working Group aims to explore how and to what extent multimorbidity can be reflected in guideline development.Single disease guidelines contribute to 'too much medicine', including the abundance of diagnostic and therapeutic measures with potential harm to the patient.The 'less is more' approach includes communication on patient outcomes, recommendations for deprescribing and awareness of climate impact.Guidelines supporting person-centred care could reduce the risk of low-value care for multimorbid patients, which will benefit both individual and planetary health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.